Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,2,4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase
Daniela Carbone, Barbara Parrino, Stella Cascioferro, et al.
ChemMedChem (2020) Vol. 16, Iss. 3, pp. 537-554
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Synthesis, computational chemical study, antiproliferative activity screening, and molecular docking of some thiophene-based oxadiazole, triazole, and thiazolidinone derivatives
Amna S. Elgubbi, Eman A. E. El‐Helw, Abdullah Yahya Abdullah Alzahrani, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5926-5940
Open Access | Times Cited: 15
GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100779-100779
Open Access | Times Cited: 63
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 37
Oxadiazole: A highly versatile scaffold in drug discovery
Nisheeth C. Desai, Jahnvi D. Monapara, Aratiba M. Jethawa, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 35
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3679-3679
Open Access | Times Cited: 29
Advances and Prospects in the Treatment of Pancreatic Cancer
Huaiyu Duan, li li, Shiming He
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3973-3988
Open Access | Times Cited: 27
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 288-288
Open Access | Times Cited: 24
Biological Characterization of One Oxadiazole Derivative (5(4‐Hydroxyphenyl)‐2‐(N‐Phenyl Amino)‐1,3,4‐Oxadiazole): In Vitro, In Silico, and Network Pharmacological Approaches
Tuğçe Duran, Irem Balikci, Busra Buyukkosucu, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Closed Access
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone, Camilla Pecoraro, Giovanna Panzeca, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 412-412
Open Access | Times Cited: 19
Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development
Mengwei Xu, Zhaofang Bai, Baocheng Xie, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 933-933
Open Access | Times Cited: 5
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
Simone Di Franco, Barbara Parrino, Miriam Gaggianesi, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102664-102664
Open Access | Times Cited: 38
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 19-19
Open Access | Times Cited: 31
New Prenylated Indole Homodimeric and Pteridine Alkaloids from the Marine-Derived Fungus Aspergillus austroafricanus Y32-2
Peihai Li, Mengqi Zhang, Haonan Li, et al.
Marine Drugs (2021) Vol. 19, Iss. 2, pp. 98-98
Open Access | Times Cited: 23
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 2
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
Faustino Mollinedo, Consuelo Gajate
Cancers (2021) Vol. 13, Iss. 16, pp. 4173-4173
Open Access | Times Cited: 15
Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
Omer H. Elmadbouh, Stephen J. Pandol, Mouad Edderkaoui
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14133-14133
Open Access | Times Cited: 10
Glycogen synthase kinase-3β inhibitors as a novel promising target in the treatment of cancer: Medicinal chemistry perspective
Dipanjan Karati, Kaustav K. Shaoo, Kakasaheb Mahadik, et al.
Results in Chemistry (2022) Vol. 4, pp. 100532-100532
Open Access | Times Cited: 9
Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative Pathogens
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
Marine Drugs (2024) Vol. 22, Iss. 3, pp. 133-133
Open Access | Times Cited: 1
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy
S. Maurya, Divya Prasad, Sayali Mukherjee
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 3-17
Closed Access | Times Cited: 4
Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?
Camilla Pecoraro, Daniela Carbone, Stella Cascioferro, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 7, pp. 776-782
Closed Access | Times Cited: 8
Dualism of 1,2,4-oxadiazole ring in noncovalent interactions with carboxylic group
Sergey V. Baykov, Marina V. Tarasenko, Artem V. Semenov, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 132974-132974
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top